(Q39341619)

11 September 2017

title

Immune complexes and antinuclear, antinucleolar, and anticentromere antibodies in scleroderma (English)

1 reference

11 September 2017

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70191-5

4 September 2023

author name string

Z. Y. Chen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6237134

4 September 2023

G. Virella

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6237134

4 September 2023

H. E. Tung

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6237134

4 September 2023

S. K. Ainsworth

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6237134

4 September 2023

R. M. Silver

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6237134

4 September 2023

A. C. Wang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6237134

4 September 2023

M. F. LaVia

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6237134

4 September 2023

H. R. Maricq

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6237134

4 September 2023

R. L. Dobson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6237134

4 September 2023

language of work or name

English

0 references

publication date

1 September 1984

1 reference

full work available at URL

11 September 2017

https://api.elsevier.com/content/article/PII:S0190962284701915?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70191-5

https://api.elsevier.com/content/article/PII:S0190962284701915?httpAccept=text/plain

4 September 2023

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70191-5

Journal of the American Academy of Dermatology

4 September 2023

published in

1 reference

11 September 2017

volume

11

1 reference

11 September 2017

issue

3

1 reference

11 September 2017

page(s)

461-467

1 reference

Pathogenesis of systemic sclerosis: A vascular hypothesis

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970191-5

7 January 2021

Circulating immune complexes in systemic scleroderma and generalized morphea

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970191-5

7 January 2021

Circulating immune complexes in patients with progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970191-5

7 January 2021

Combined titre and fluorescent pattern of IgG antinuclear antibodies using cultured cell monolayers in evaluating connective tissue diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970191-5

7 January 2021

Cardiopulmonary manifestations of progressive systemic sclerosis: associations with circulating immune complexes and fluorescent antinuclear antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970191-5

7 January 2021

Antinucleolar antibodies. Their frequency and diagnostic association

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970191-5

7 January 2021

Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970191-5

7 January 2021

Antinuclear antibodies as immunologic markers for a benign subset and different clinical characteristics of scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970191-5

7 January 2021

The CREST syndrome: a distinct serologic entity with anticentromere antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970191-5

7 January 2021

Anticentromere and anticentriole antibodies in the scleroderma spectrum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970191-5

7 January 2021

Anticentromere antibody. Clinical Correlations and association with favorable prognosis in patients with scleroderma variants

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970191-5

7 January 2021

Microhemagglutination Test for Detection of Antibodies to Nuclear Sm and Ribonucleoprotein Antigens in Systemic Lupus Erythematosus and Related Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970191-5

7 January 2021

Preparation of 125I polypeptide hormones for radioimmunoassay using glucose oxidase with lactoperoxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970191-5

7 January 2021

Immunohistochemical findings in the renal vascular lesions of progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970191-5

7 January 2021

Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970191-5

7 January 2021

Direct immunofluorescence in the diagnosis of scleroderma syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970191-5

7 January 2021

Immunofluorescence studies in progressive systemic sclerosis (scleroderma) and mixed connective tissue disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970191-5

7 January 2021

Immune complexes in progressive systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970191-5

7 January 2021

Detection of circulating immune comlexes in some skin diseases by platelet aggregation test

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970191-5

7 January 2021

Detection of immune complexes in systemic sclerosis and Raynaud's phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2884%2970191-5

7 January 2021

Immunopathology of the renal vascular lesion of progressive systemic sclerosis (scleroderma)

5

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70191-5

Immune complexes in progressive systemic sclerosis and mixed connective tissue disease

4 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70191-5

Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis

4 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70191-5

Antinuclear antibodies: their significance in scleroderma

4 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70191-5

Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease

4 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70191-5

Statistical analysis of five immune complex screening assays: patterns of detection in patients with rheumatoid arthritis, systemic lupus erythematosus, infectious endocarditis, and diabetes mellitus

4 September 2023

28

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70191-5

Direct immunofluorescent findings in scleroderma syndromes

4 September 2023

34

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70191-5

Circulating immune complexes in lupus erythematosus, scleroderma and dermatomyositis

4 September 2023

39

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(84)70191-5

4 September 2023

Identifiers

1 reference

release_dkhfruaahzbn3cfq7ktfiz64u4

11 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dkhfruaahzbn3cfq7ktfiz64u4

24 November 2022

mapped directly with Wikidata item

1 reference